Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

FRA:B7E - Deutsche Boerse Ag - DE000A0JM2M1 - Common Stock - Currency: EUR

17.7  +0.1 (+0.57%)

Fundamental Rating

5

B7E gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 109 industry peers in the Capital Markets industry. Both the profitability and the financial health of B7E get a neutral evaluation. Nothing too spectacular is happening here. B7E is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year B7E was profitable.
B7E had a positive operating cash flow in the past year.
Of the past 5 years B7E 4 years were profitable.
In the past 5 years B7E always reported a positive cash flow from operatings.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.14%, B7E is in the better half of the industry, outperforming 77.98% of the companies in the same industry.
B7E has a Return On Equity of 13.94%. This is in the better half of the industry: B7E outperforms 71.56% of its industry peers.
B7E has a Return On Invested Capital of 3.95%. This is in the better half of the industry: B7E outperforms 61.47% of its industry peers.
B7E had an Average Return On Invested Capital over the past 3 years of 5.02%. This is below the industry average of 8.40%.
Industry RankSector Rank
ROA 6.14%
ROE 13.94%
ROIC 3.95%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

B7E has a Profit Margin (6.44%) which is in line with its industry peers.
In the last couple of years the Profit Margin of B7E has grown nicely.
B7E has a Operating Margin of 4.18%. This is comparable to the rest of the industry: B7E outperforms 52.29% of its industry peers.
B7E's Operating Margin has improved in the last couple of years.
B7E's Gross Margin of 50.05% is fine compared to the rest of the industry. B7E outperforms 64.22% of its industry peers.
In the last couple of years the Gross Margin of B7E has grown nicely.
Industry RankSector Rank
OM 4.18%
PM (TTM) 6.44%
GM 50.05%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The number of shares outstanding for B7E remains at a similar level compared to 1 year ago.
Compared to 5 years ago, B7E has more shares outstanding
Compared to 1 year ago, B7E has an improved debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.16 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of B7E (2.16) is better than 66.06% of its industry peers.
B7E has a debt to FCF ratio of 9.68. This is a negative value and a sign of low solvency as B7E would need 9.68 years to pay back of all of its debts.
B7E has a Debt to FCF ratio of 9.68. This is in the better half of the industry: B7E outperforms 69.72% of its industry peers.
B7E has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of B7E (0.38) is better than 65.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 9.68
Altman-Z 2.16
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

B7E has a Current Ratio of 1.65. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E has a Current ratio of 1.65. This is in the better half of the industry: B7E outperforms 73.39% of its industry peers.
B7E has a Quick Ratio of 1.36. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.36, B7E is in the better half of the industry, outperforming 68.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.36
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 172.52% over the past year.
The Earnings Per Share has been growing by 33.00% on average over the past years. This is a very strong growth
B7E shows a decrease in Revenue. In the last year, the revenue decreased by -5.86%.
The Revenue has been decreasing by -1.79% on average over the past years.
EPS 1Y (TTM)172.52%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%234.37%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%4.56%

3.2 Future

The Earnings Per Share is expected to decrease by -49.11% on average over the next years. This is quite bad
The Revenue is expected to grow by 3.43% on average over the next years.
EPS Next Y-81.13%
EPS Next 2Y-49.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.09%
Revenue Next 2Y3.28%
Revenue Next 3Y6.51%
Revenue Next 5Y3.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

B7E is valuated cheaply with a Price/Earnings ratio of 6.08.
Based on the Price/Earnings ratio, B7E is valued cheaply inside the industry as 94.50% of the companies are valued more expensively.
B7E's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.21.
A Price/Forward Earnings ratio of 20.38 indicates a rather expensive valuation of B7E.
Based on the Price/Forward Earnings ratio, B7E is valued a bit cheaper than the industry average as 64.22% of the companies are valued more expensively.
B7E is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.08
Fwd PE 20.38
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

B7E's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. B7E is cheaper than 93.58% of the companies in the same industry.
88.07% of the companies in the same industry are more expensive than B7E, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.06
EV/EBITDA 3.73
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

B7E has a very decent profitability rating, which may justify a higher PE ratio.
B7E's earnings are expected to decrease with -49.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-49.11%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.63%, B7E has a reasonable but not impressive dividend return.
B7E's Dividend Yield is a higher than the industry average which is at 5.70.
B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

21.99% of the earnings are spent on dividend by B7E. This is a low number and sustainable payout ratio.
The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP21.99%
EPS Next 2Y-49.11%
EPS Next 3YN/A
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
B7E.DE Dividend Payout.B7E.DE Dividend Payout, showing the Payout Ratio.B7E.DE Dividend Payout.PayoutRetained Earnings

BLUE CAP AG

FRA:B7E (7/1/2025, 7:00:00 PM)

17.7

+0.1 (+0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-20 2025-08-20
Inst Owners25.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap79.47M
Analysts82.86
Price Target30.6 (72.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP21.99%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.64%
PT rev (3m)-0.99%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.85%
Valuation
Industry RankSector Rank
PE 6.08
Fwd PE 20.38
P/S 0.39
P/FCF 10.06
P/OCF 6.11
P/B 0.84
P/tB 1.78
EV/EBITDA 3.73
EPS(TTM)2.91
EY16.44%
EPS(NY)0.87
Fwd EY4.91%
FCF(TTM)1.76
FCFY9.94%
OCF(TTM)2.89
OCFY16.35%
SpS45.86
BVpS21.18
TBVpS9.95
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 13.94%
ROCE 5.68%
ROIC 3.95%
ROICexc 6.3%
ROICexgc 13.24%
OM 4.18%
PM (TTM) 6.44%
GM 50.05%
FCFM 3.84%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexcg growth 3Y54.39%
ROICexcg growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 9.68
Debt/EBITDA 1.4
Cap/Depr 29.84%
Cap/Sales 2.47%
Interest Coverage 1.83
Cash Conversion 50.62%
Profit Quality 59.6%
Current Ratio 1.65
Quick Ratio 1.36
Altman-Z 2.16
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)172.52%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%234.37%
EPS Next Y-81.13%
EPS Next 2Y-49.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%4.56%
Revenue Next Year2.09%
Revenue Next 2Y3.28%
Revenue Next 3Y6.51%
Revenue Next 5Y3.43%
EBIT growth 1Y33.24%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-23.35%
EBIT Next 3Y-2.93%
EBIT Next 5Y-2.15%
FCF growth 1Y-21.47%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-11.77%
OCF growth 3Y1.47%
OCF growth 5Y47.8%